RVPH
USDReviva Pharmaceuticals Holdings Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$0.570
Máximo
$0.595
Mínimo
$0.530
Volumen
5.53M
Fundamentos de la Empresa
Capitalización de Mercado
53.3M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
9.52M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals with a Buy and maintains $2 price target.
HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals with a Buy and lowers the price target from $11 to $4.
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners
CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet
Acciones Relacionadas
FBYD
Falcon's Beyond Global Inc.
WHF
WhiteHorse Finance Inc.
HTLFP
Heartland Financial USA Inc. Depositary Shares each representing a 1/400th ownership interest in a share of 7.00% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E
HTGC
Hercules Capital Inc.
BCAB
BioAtla Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.